Evolution of HER2-low expression from primary to paired metastatic gastric cancer lesions

Abstract HER2-low expression has recently gained considerable attention as an actionable biomarker in gastric cancer. However, changes in HER2-low expression between primary and metastatic gastric cancers remain inadequately explored. This study included consecutive patients diagnosed with metastati...

Full description

Saved in:
Bibliographic Details
Main Authors: Wen-Zhuo He, Yuan-Zhong Yang, Chen-Xi Yin, Xin-Yi Xian, Jia-Mei Gu, Jia-Hong Yi, Ju Xue, Yue Zhao, Fang Wang, Wan-Ming Hu, Liang-Ping Xia
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-025-00881-1
Tags: Add Tag
No Tags, Be the first to tag this record!